(FM) Alergología e Inmunología Clínica
Departamento académico
![Foto de Antonio Luis](/img/nophoto.png)
Antonio Luis
Valero Santiago
Publications dans lesquelles il/elle collabore avec Antonio Luis Valero Santiago (41)
2022
-
Consensus on the Definition of Control and Remission in Chronic Urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269
-
Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14
2019
-
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
Health and Quality of Life Outcomes, Vol. 17, Núm. 1
-
Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348
2017
-
Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe
Rhinology, Vol. 55, Núm. 1, pp. 34-38
-
Allergy rhinitis: Similarities and differences between children and adults
Rhinology, Vol. 55, Núm. 4, pp. 326-331
-
Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144
-
Mechanisms, cofactors, and augmenting factors involved in anaphylaxis
Frontiers in Immunology
-
Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
Scientific Reports, Vol. 7, Núm. 1
2016
-
Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study
Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870
-
Comparable actions of omalizumab on mast cells and basophils
Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102
2015
-
Management of urticaria: Not too complicated, not too simple
Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743
2014
-
Assessment of severity and quality of life in chronic urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 2, pp. 80-86
2013
-
Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain
Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684
-
Antihistamines in drivers, aircrew and occupations of risk.
Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 27-34
-
Bilastine for the treatment of urticaria
Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544
-
ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications
Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19
-
Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice
Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228
-
H1 antihistamines and benzodiazepines. Pharmacological interactions and their impact on cerebral function.
Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 17-26
-
Use of second generation H1 antihistamines in special situations.
Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 1-16